Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Clinical Study to Demonstrate the Safety and Effectiveness of the ShortCut™ Device (The ShortCut™ Study)

NCT04952909 is registered in ClinicalTrials.gov with Pi-cardia as lead sponsor.

NCT NCT04952909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04952909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Clinical Study to Demonstrate the Safety and Effectiveness of the ShortCut™ Device (The ShortCut™ Study)
Lead sponsor
Pi-cardia
Phase
Not applicable
Overall status
Completed
Start date
January 21, 2022
Completion date
December 31, 2023
Enrollment
60 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

risk of coronary obstruction following transcatheter aortic valve replacement (tavr) procedure